{"id":"W4280609207","doi":"10.1016/j.ahj.2022.05.010","title":"Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial","year":2022,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"British Heart Foundation","keywords":"Empagliflozin; Medicine; Myocardial infarction; Ejection fraction; Heart failure; Placebo; Internal medicine; Hazard ratio; Population; Cardiology; Clinical endpoint; Randomized controlled trial; Intensive care medicine; Diabetes mellitus; Type 2 diabetes; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01009345,0.001581505,0.002283595,0.000395937,0.0007569917,0.001779616,0.001010054,0.002332264,0.01024455],"category_scores_gemma":[0.007109665,0.0006623435,0.001374388,0.0005846579,0.001236571,0.001247771,0.0008157402,0.002575537,0.002369582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006022496,"about_ca_system_score_gemma":0.00200292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003433478,"about_ca_topic_score_gemma":0.0005975523,"domain_scores_codex":[0.9955351,0.003083593,0.0002782714,0.0005184307,0.0003441525,0.0002403477],"domain_scores_gemma":[0.9983965,0.0003630691,0.0003830983,0.0001680635,0.0002113698,0.000477913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.883705,0.008650543,0.009563866,0.00561938,0.001999631,0.0002340092,0.0001708403,0.001767754,0.00261135,0.004597933,0.01809291,0.06298683],"study_design_scores_gemma":[0.9302188,0.03306562,0.009077936,0.0009111802,0.001501474,0.0001402884,0.0000448514,0.001605559,0.0004738555,0.002873735,0.02002825,0.00005847288],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.3769147,0.05912967,0.02015078,0.02115762,0.008364025,0.4409734,0.01923678,0.0005456615,0.05352737],"genre_scores_gemma":[0.4746961,0.01071828,0.0220296,0.01432141,0.004022251,0.4567797,0.007478416,0.00007174043,0.009882515],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.01024455,"threshold_uncertainty_score":0.05337989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01837511195412276,"score_gpt":0.2627465102786291,"score_spread":0.2443713983245063,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}